Form 4: Entero Therapeutics Insider Receives Stock Grant
Insider Transaction (Form 4)
Manpreet Uppal, Former director of Entero Therapeutics, Inc., received 20,000 shares of common stock on October 19, 2026.
Summary
- Grant/award: acquired 20,000 Common Stock on October 19, 2026; holds 60,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Manpreet Uppal — Other (Former director)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-19 | Grant/award | Common Stock | 20,000 | — | — | 60,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-19 | Grant/award (20,000 shares) |
Keywords
insider transaction, Form 4, GRDX, GridAI Technologies Corp., neutral, Manpreet Uppal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.